It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Accumulating evidence suggests that modifications of gut function and microbiota composition might play a pivotal role in the pathophysiology of several cardiovascular diseases, including heart failure (HF). In this study we systematically analysed gut microbiota composition, intestinal barrier integrity, intestinal and serum cytokines and serum endotoxin levels in C57BL/6 mice undergoing pressure overload by transverse aortic constriction (TAC) for 1 and 4 weeks. Compared to sham-operated animals, TAC induced prompt and strong weakening of intestinal barrier integrity, long-lasting decrease of colon anti-inflammatory cytokine levels, significant increases of serum levels of bacterial lipopolysaccharide and proinflammatory cytokines. TAC also exerted effects on microbiota composition, inducing significant differences in bacterial genera inside Actinobacteria, Firmicutes, Proteobacteria and TM7 phyla as shown by 16S rDNA sequencing of fecal samples from TAC or sham mice. These results suggest that gut modifications represent an important element to be considered in the development and progression of cardiac dysfunction in response to TAC and support this animal model as a valuable tool to establish the role and mechanisms of gut-heart crosstalk in HF. Evidence arising in this field might identify new treatment options targeting gut integrity and microbiota components to face adverse cardiac events.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Federico II University, Department of Advanced Biomedical Sciences, Naples, Italy (GRID:grid.4691.a) (ISNI:0000 0001 0790 385X)
2 Fondazione Umberto Veronesi, Milan, Italy (GRID:grid.478935.4) (ISNI:0000 0000 9193 5936); Federico II University, Department of Pharmacy, Naples, Italy (GRID:grid.4691.a) (ISNI:0000 0001 0790 385X); University of Malta, Department of Physiology and Biochemistry, Faculty of Medicine and Surgery, Msida, Malta (GRID:grid.4462.4) (ISNI:0000 0001 2176 9482); Federico II University, Task Force On Microbiome Studies, Naples, Italy (GRID:grid.4691.a) (ISNI:0000 0001 0790 385X)
3 Federico II University, Department of Pharmacy, Naples, Italy (GRID:grid.4691.a) (ISNI:0000 0001 0790 385X); Federico II University, Task Force On Microbiome Studies, Naples, Italy (GRID:grid.4691.a) (ISNI:0000 0001 0790 385X)
4 Federico II University, Department of Molecular Medicine and Medical Biotechnology, Naples, Italy (GRID:grid.4691.a) (ISNI:0000 0001 0790 385X)
5 Federico II University, Department of Veterinary Medicine and Animal Productions, Unit of Pathology, Naples, Italy (GRID:grid.4691.a) (ISNI:0000 0001 0790 385X)
6 Federico II University, Department of Biology, Naples, Italy (GRID:grid.4691.a) (ISNI:0000 0001 0790 385X)
7 Federico II University, Department of Veterinary Medicine and Animal Productions, Unit of Pathology, Naples, Italy (GRID:grid.4691.a) (ISNI:0000 0001 0790 385X); Federico II University, Task Force On Microbiome Studies, Naples, Italy (GRID:grid.4691.a) (ISNI:0000 0001 0790 385X)
8 Federico II University, Task Force On Microbiome Studies, Naples, Italy (GRID:grid.4691.a) (ISNI:0000 0001 0790 385X); Federico II University, Department of Biology, Naples, Italy (GRID:grid.4691.a) (ISNI:0000 0001 0790 385X)